APAC Diagnostics Imaging Equipment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Asia Pacific Diagnostics Imaging Equipment Market Report is segmented by Product (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications), End-User (Hospital, Diagnostic Centers, Others) and Geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The market size and forecast values are provided in terms of (USD) for all the above segments.

APAC Diagnostics Imaging Equipment Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

APAC Diagnostics Imaging Devices Market Size

View Global Report
Asia-Pacific Diagnostic Imaging Equipment Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 7.50 %
Market Concentration Medium

Major Players

Asia-Pacific Diagnostic Imaging Equipment Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Asia-Pacific Diagnostic Imaging Equipment Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

APAC Diagnostics Imaging Devices Market Analysis

The Asia-Pacific Diagnostic Imaging Equipment Market is expected to register a CAGR of 7.5% during the forecast period.

The COVID-19 epidemic caused several significant problems for the healthcare sector. Since the majority of chronic therapies were considered non-urgent during the COVID-19 pandemic, all outpatient treatments were delayed or restricted to lower the danger of viral transmission. Lung imaging, however, became a significant component of COVID-19 diagnoses with the emergence of the infection, as it assisted in determining the severity of the illness in the afflicted population. According to a study published in the Indian Journal of Radiology and Imaging in January 2021, portable chest radiography had become a popular technique for rapidly assessing the degree of lung involvement in COVID-19 pneumonia in hospitalized symptomatic patients and calculating its progression. As a result, the use of diagnostic imaging grew during COVID-19 and had a favorable influence on the market. However, currently, the market has reached its pre-pandemic nature in terms of diagnostic imaging procedures and is expected to witness strong growth in the coming years.

Factors such as an increase in the prevalence of chronic diseases, technological advancements in imaging modalities, and the growing need for early diagnostics are driving the market.

There is a growing burden of life-threatening chronic diseases in Asian countries, which is one of the leading factors responsible for the market growth in the region. For instance, a research article by the National Institute of Health published in August 2021 highlighted in their research paper that both the prevalence and incidence of heart failure (HF) increase with increasing age and that HF places a considerable burden on health systems in China. Thus, the burden of cardiovascular diseases among the target populations in the countries of the Asia-Pacific region is expected to demand the availability of diagnostic imaging products for disease diagnosis and treatment. As a result, it is expected to contribute to market growth.

Furthermore, with the technological innovation in the area, many products are expected to be launched over the forecast period, which may also positively impact market growth. For instance, in April 2022, Wipro GE Healthcare announced the release of an innovative imaging solution that was entirely developed and produced in India. In accordance with the Atma Nirbhar Bharat mission, the imaging solution, the Revolution Aspire CT (computerized tomography) scanner, was produced at the recently opened Wipro GE Medical Devices Manufacturing unit. With the release of these new imaging devices in Asian countries, the market that was looked at is expected to grow quickly over the next few years.

However, the high cost of instruments and lack of skilled radiologists have been restraining the growth of this market.

APAC Diagnostics Imaging Devices Industry Overview

The major players in the Asia-Pacific diagnostic imaging equipment market include Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Koninklijke Philips N.V., Shimadzu Corporation, Siemens AG, Canon Medical Systems Corporation, and Shanghai United Imaging Healthcare Co., Ltd., among others. The leading vendors in the market are launching advanced diagnostic imaging equipment. These companies have also been involved in the acquisition of related healthcare companies in order to improve their product portfolio, geographical presence, and growth.

APAC Diagnostics Imaging Devices Market Leaders

  1. Carestream Health

  2. Fujifilm Holdings Corporation

  3. Hologic, Inc

  4. Koninklijke Philips N.V.

  5. GE Healthcare

  6. *Disclaimer: Major Players sorted in no particular order
Asia-Pacific Diagnostic Imaging Equipment Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

APAC Diagnostics Imaging Devices Market News

  • October 2022: Luxonus Inc. received approval to market its photoacoustic 3D imaging system in Japan.
  • February 2022: Siemens Healthineers and Universal Medical Imaging have signed a strategic collaboration agreement to help primary healthcare facilities in China improve the accuracy of their image screening and disease diagnosis using cutting-edge imaging diagnostic tools and remote scanning assistant equipment from Siemens Healthineers and the local medical imaging experts at Universal Medical Imaging.

APAC Diagnostics Imaging Devices Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Chronic Diseases
    • 4.2.2 Technological Advancement in Imaging Modalities
    • 4.2.3 Growing Emphasis on Early Diagnosis
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Radiologist
    • 4.3.2 High Cost of Advanced Diagnostic Imaging Devices
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Modality
    • 5.1.1 MRI
    • 5.1.1.1 Low and mid field MRI systems (<1.5 T)
    • 5.1.1.2 High field MRI systems (1.5-3 T)
    • 5.1.1.3 Very High, and Ultra High Field MRI Systems (3T and more)
    • 5.1.2 Computed Tomography
    • 5.1.2.1 Low End Scanners (~16-Slice)
    • 5.1.2.2 Mid Range Scanners (~64-Slice)
    • 5.1.2.3 High End Scanners (128-Slice and More)
    • 5.1.3 Ultrasound
    • 5.1.3.1 2D Ultrasound
    • 5.1.3.2 3D Ultrasound
    • 5.1.3.3 Other Types of Ultrasound
    • 5.1.4 X-Ray
    • 5.1.4.1 Analog Systems
    • 5.1.4.2 Digital Systems
    • 5.1.5 Nuclear Imaging
    • 5.1.5.1 Positron Emission Tomography (PET)
    • 5.1.5.2 Single Photon Emission Computed Tomography (SPECT)
    • 5.1.6 Fluoroscopy
    • 5.1.7 Mammography
  • 5.2 By Application
    • 5.2.1 Cardiology
    • 5.2.2 Oncology
    • 5.2.3 Neurology
    • 5.2.4 Orthopedics
    • 5.2.5 Gastroenterology
    • 5.2.6 Gynecology
    • 5.2.7 Other Applications
  • 5.3 By End-User
    • 5.3.1 Hospital
    • 5.3.2 Diagnostic Centers
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 China
    • 5.4.2 Japan
    • 5.4.3 India
    • 5.4.4 Australia
    • 5.4.5 South Korea
    • 5.4.6 Rest of Asia-Pacific

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Carestream Health
    • 6.1.2 FUJIFILM Holdings Corporation
    • 6.1.3 GE Healthcare
    • 6.1.4 Hologic, Inc.
    • 6.1.5 Koninklijke Philips N.V.
    • 6.1.6 Shanghai United Imaging Healthcare Co., Ltd
    • 6.1.7 Shimadzu Corporation
    • 6.1.8 Siemens AG
    • 6.1.9 Canon Medical Systems Corporation
    • 6.1.10 Esaote SpA
    • 6.1.11 Teknova Medical Systems Limited
    • 6.1.12 J. Morita Corporation
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

APAC Diagnostics Imaging Devices Industry Segmentation

As per the scope of the report, diagnostic imaging is used to take images of the internal structure of the human body using electromagnetic radiation for an accurate diagnosis of the patient. Diagnostic imaging uses radiation to diagnose and treat diseases. The Asia-Pacific Diagnostic Imaging Equipment Market is segmented by product (MRI, Computed Tomography, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, and Mammography), application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Other Applications), end-user (Hospitals, Diagnostic Centers, Others), and geography (China, Japan, India, Australia, South Korea, Rest of Asia-Pacific). The report offers the value (in USD million) for the above segments.

By Modality MRI Low and mid field MRI systems (<1.5 T)
High field MRI systems (1.5-3 T)
Very High, and Ultra High Field MRI Systems (3T and more)
Computed Tomography Low End Scanners (~16-Slice)
Mid Range Scanners (~64-Slice)
High End Scanners (128-Slice and More)
Ultrasound 2D Ultrasound
3D Ultrasound
Other Types of Ultrasound
X-Ray Analog Systems
Digital Systems
Nuclear Imaging Positron Emission Tomography (PET)
Single Photon Emission Computed Tomography (SPECT)
Fluoroscopy
Mammography
By Application Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Other Applications
By End-User Hospital
Diagnostic Centers
Other End-Users
Geography China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Need A Different Region or Segment?
Customize Now

APAC Diagnostics Imaging Devices Market Research FAQs

What is the current Asia-Pacific Diagnostic Imaging Equipment Market size?

The Asia-Pacific Diagnostic Imaging Equipment Market is projected to register a CAGR of 7.5% during the forecast period (2025-2030)

Who are the key players in Asia-Pacific Diagnostic Imaging Equipment Market?

Carestream Health, Fujifilm Holdings Corporation, Hologic, Inc, Koninklijke Philips N.V. and GE Healthcare are the major companies operating in the Asia-Pacific Diagnostic Imaging Equipment Market.

What years does this Asia-Pacific Diagnostic Imaging Equipment Market cover?

The report covers the Asia-Pacific Diagnostic Imaging Equipment Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific Diagnostic Imaging Equipment Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Asia-Pacific Diagnostics Imaging Devices Industry Report

Statistics for the 2025 Asia-Pacific Diagnostic Imaging Equipment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Diagnostic Imaging Equipment analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.